Comparison of the Efficacy and Acceptability of Three Types of Micronutrient Supplements in Ghana

Micronutrients Clinical Trial

Official title:

Comparison of the Efficacy and Acceptability of Three Types of Micronutrient Supplements Added to Complementary Foods for Infants in Ghana

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00379158
• Other study ID #: 200210085
• Status: Completed
• Phase: Phase 4
• First received: September 20, 2006
• Last updated: May 24, 2017
• Start date: October 2003
• Est. completion date: April 2005

Study information

• Verified date: May 2017
• Source: University of California, Davis
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

1. At 12 mo of age, all three intervention groups will have significantly better iron and vitamin A status than the NI group.

2. Infants who receive the Foodlet or Nutributter will have significantly greater weight and length gains from 6 to 12 mo and higher indices of vitamin B6, riboflavin and zinc status at 12 mo of age than the infants who receive the sprinkles containing iron and vitamin A only.

3. Infants who receive Nutributter will have significantly greater weight and length gains from 6 to 12 mo and higher indices of vitamin A and essential fatty acid (linoleic, alpha-linolenic and docosahexaenoic, DHA) status at 12 mo of age than the infants who receive the Foodlet or sprinkles.

Description:

Study design

We propose to conduct a randomized controlled study of infants recruited from Maternal and Child Health centers in the town of Koforidua, located in eastern Ghana. There are 8 such centers located in various parts of the town, each of which serves the mothers and children in the immediate vicinity. The vast majority of infants born in Koforidua are brought to the MCH centers beginning a few weeks after birth for monthly weight monitoring. A list of all infants attending the MCH centers who are approximately 5 mo of age, have no congenital abnormality or chronic disease, and are currently breastfed will be created during each clinic day. From these lists we will randomly select approximately 34 infants per month (during a recruitment period of 9 mo) who will be invited to participate in the intervention trial. These infants will then be randomly assigned to one of three groups:

1. "Sprinkles" group: Will receive micronutrient Sprinkles beginning at 6 mo of age.

2. "Foodlet" group: Will receive crushable multiple micronutrient tablet beginning at 6 mo of age.

3. "Nutributter" group: Will receive fat-based supplement (Nutributter) beginning at 6 mo of age

We have chosen not to include a negative control (placebo) group because there is a high rate of iron and vitamin A deficiency in this population, and we cannot leave children who are known to be anemic untreated during the 6-mo study period. Instead, we will assess a "Non-Intervention" (NI) group of infants at 12 mo of age, which will allow us to evaluate attained size and micronutrient status in the absence of any intervention. The NI group will be randomly selected from the subset of infants who were recorded on the MCH lists described above during the recruitment period for the intervention trial (and thus met the same selection criteria), but not randomly selected for the intervention trial. [We cannot take all of the infants who come to the MCH clinics each month because the field work would be unmanageable. Given the birth rate of 179/mo, there will be more than enough "left over" each month who won't be selected for the intervention, and from whom we can randomly select the non-intervention group once they reach 12 mo.] We plan to recruit approximately 9/mo for the NI group for a period of 9 months, starting 6 mo after we initiate recruitment for the intervention (i.e., when the "left-over" infants begin to reach 12 mo of age). The MCH lists will include contact information (address), so that we can find the NI mothers at 12 mo. When we contact them at 12 mo, we will confirm that their infants would have met the eligibility criteria for the intervention study (breastfed at 5 mo, and free of congenital abnormality, chronic disease or peanut allergy), and ask them to participate in the one-time assessment. At that time each NI family will be given compensation equivalent in value to the supplements provided to the intervention groups (such as a 6-mo supply of Nutributter).

Study site The study will be conducted in Koforidua, which has a population of about 87,000 and an average birth rate of 179/mo (between 1998 and 2001).

The University of Ghana will administer the project and provide scientific and technical support for the study. It will also provide office space for administrative tasks and laboratories for biochemical analyses of blood samples. UC Davis will provide supervision of the study through the Project Manager (Seth Adu-Afarwuah, a doctoral student at UC Davis), and will order and ship all of the necessary supplies and equipment.

Informed consent procedures: Approval for the study has been obtained from the UC Davis Human Subjects Review Committee and the University of Ghana (Noguchi Memorial Institute) Ethics Committee. Consent to conduct the study in the town will be obtained from the Koforidua Municipal Health Administration. Written consent to participate in the study will be obtained individually from the mothers of the infants. Consent forms explaining the purpose of the study, potential risks or discomfort, the rights of subjects and the benefits to the subjects will be available both in English and in the local language, Asante Twi. For illiterate mothers unable to read, the form will be read and explained to them in Asante Twi. To indicate their consent, mothers will be asked to either sign the consent form or thumb-print it.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 393
• Est. completion date: April 2005
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 5 Months to 6 Months

Eligibility

Inclusion Criteria:

• approximately 5 mo of age

• receiving breast milk

• free of congenital abnormality

• expected to stay in the town for at least the subsequent six months.

Exclusion Criteria:

• medically diagnosed chronic illness (including asthma or eczema)

Related Conditions & MeSH terms

• Micronutrients

Intervention

Drug:
• Micronutrient supplements

Locations

Country	Name	City	State
n/a

Sponsors (3)

Lead Sponsor	Collaborator
University of California, Davis	Nestlé Foundation, United States Agency for International Development (USAID)

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Growth (weight, length, head circumference)
Primary	Hemoglobin
Primary	Micronutrient status (Iron, retinol, B2, B6, zinc, plasma fatty acids)
Secondary	Motor milestone acquisition
Secondary	Morbidity
Secondary	Energy intake from complementary foods